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Hydrogen sulﬁde (H2S) is an important gaseous signaling molecule in the cardiovascular system. In
addition to free H2S, H2S can be oxidized to polysulﬁde which can be biologically active. Since the impact
of H2S on endothelial solute barrier function is not known, we sought to determine whether H2S and its
various metabolites affect endothelial permeability. In vitro permeability was evaluated using albumin
ﬂux and transendothelial electrical resistance. Different H2S donors were used to examine the effects of
exogenous H2S. To evaluate the role of endogenous H2S, mouse aortic endothelial cells (MAECs) were
isolated from wild type mice and mice lacking cystathionine γ-lyase (CSE), a predominant source of H2S
in endothelial cells. In vivo permeability was evaluated using the Miles assay. We observed that poly-
sulﬁde donors induced rapid albumin ﬂux across endothelium. Comparatively, free sulﬁde donors in-
creased permeability only with higher concentrations and at later time points. Increased solute per-
meability was associated with disruption of endothelial junction proteins claudin 5 and VE-cadherin,
along with enhanced actin stress ﬁber formation. Importantly, sulﬁde donors that increase permeability
elicited a preferential increase in polysulﬁde levels within endothelium. Similarly, CSE deﬁcient MAECs
showed enhanced solute barrier function along with reduced endogenous bound sulfane sulfur. CSE
siRNA knockdown also enhanced endothelial junction structures with increased claudin 5 protein ex-
pression. In vivo, CSE genetic deﬁciency signiﬁcantly blunted VEGF induced hyperpermeability revealing
an important role of the enzyme for barrier function. In summary, endothelial solute permeability is
critically regulated via exogenous and endogenous sulﬁde bioavailability with a prominent role of
polysulﬁdes.
& 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Endothelial cells form the innermost layer of blood vessels and
serve as a barrier conﬁning blood within the vessel. This barrier
function exhibits heterogeneity across different vascular beds to
meet local tissue microenvironments and functions [3]. En-
dothelial barriers in large to medium vessels throughout the body
are considered to be largely impermeable to various molecules in
the blood under physiological conditions. In contrast, as the major
exchange vessels, capillaries witness continuous exchange of so-
luble contents between blood and the interstitial tissue. On the
other hand, permeability can be induced in other vascular bedsB.V. This is an open access article
y, Louisiana State University(predominantly in the post-capillary vanules) where basal per-
meability is low. Increased permeability is an essential part of
acute and chronic inﬂammation and is critical for compartmen-
talization and the recruitment of inﬂammatory cells. Increased
permeability may also favor angiogenesis and tissue repair by
changing extracellular matrix composition and obliterate contact
inhibition between cells [2,15]. Therefore, endothelial perme-
ability plays critical roles in vascular functions. The integrity and
complexity of intercellular junctions, including tight junctions and
adherens junctions, regulate endothelial permeability. Perme-
ability enhancers, such as vascular endothelial growth factor
(VEGF), cause cell contraction and junction disruption resulting in
intercellular gaps and increased permeability[21].
Hydrogen sulﬁde (H2S), as a gaseous signaling molecule, has
been demonstrated to be beneﬁcial for a range of cardiovascular
diseases, including peripheral and cardiac ischemia [6,24,25],
atherosclerosis[30]. Although we know that H2S is important forunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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remain unclear. A few studies investigated the role of H2S on hy-
perpermeability induced by particulate matter in the lung vascu-
lature and ischemia/reperfusion injury in brain microvessels
[14,19,41]. Yet the complexity of H2S metabolism has not been
taken into consideration.
In endothelial cells, cystathionine γ-lyase (CSE) is considered to
be a predominant source of H2S [40]. As a by-product of the
transsulfuration pathway, the level of free sulﬁde is low (i.e. H2S,
HS and S2). However, in the presence of free radicals, metal ions
and myeloperoxidase, thiyl radicals can be formed leading to
persulﬁde and polysulﬁde compound. Others and we have also
reported that H2S can be mobilized from biochemical reservoirs
such as acid labile sulfur (iron sulfur clusters), and sulfane sulfur
(e.g. thiosulﬁde, protein per/polysulﬁde) [23,36,37]. Moreover, in-
creasing evidence suggests that sulfane sulfur serves as an active
form of H2S that is highly potent and may be responsible for some
of H2S biological effects [18,29]. To better understand the effect of
H2S on endothelial permeability, we examined how exogenous
and CSE derived endogenous H2S could regulate endothelial
permeability.2. Materials and methods
2.1. Animals
All mice used in this study were housed in accordance with the
National Research Council’s Guide for the Care and Use of La-
boratory Animals. 12–20 week old male C57BL/6 J wild-type and
CSE knockout mice were used for experiments. All animal studies
were approved by the LSU Health-Shreveport institutional animal
care and use committee (Protocol Number: P-14-040).
2.2. Cell culture
Human umbilical vein endothelial cells (HUVECs) (FC-0044,
Lifeline Cell Technology) were maintained in endothelial growth
medium (LL-0003, Lifeline Cell Technology) with 10% fetal bovine
serum (FBS) at 37 °C. Mouse aortic endothelial cells (MAECs) were
isolated from wild-type and CSE knockout mice. Mice were an-
esthetized with an intraperitoneal injection of ketamine (100 mg/
kg) and xylazine (8 mg/kg) and perfused with 5 ml phosphate
buffered saline (PBS). Thoracic aortae were dissected and cut into
0.5 mm thick rings. Aortic rings pooled from 3 mice were seeded
on Matrigel (354,234, Corning) in a 6-well plate and cultured in
endothelial growth medium for 5–7 days for endothelial cells to
sprout. After removal of aortic ring, Matrigel was digested by
dispase (354,235, Corning). Cells were sorted for endoglin (CD105)
(13–1051-85, eBioscience) using Dynabeads M-280 Streptavidin
(11205D, Invitrogen) and immortalized using temperature sensi-
tive SV40 large T antigen by retrovirus. Isolated MAECs were
maintained in Dulbecco’s Modiﬁcation of Eagle’s Medium (DMEM)
(15–013-CV, Corning) with 10% FBS supplemented with Re-
combinant mouse interferon gamma (IFN-γ) (50-990-843, Fisher
Scientiﬁc) at 33 °C. For experiments, MAECs are kept at 37 °C
without INF-γ for at least 48 h for inactivation of large T-antigens.
Both HUVECs and MAECs were starved overnight with low serum
medium before experiments. Transfection was performed using
siRNA oligos and lipofectamine 2000 (11,668-019, Thero Fisher
Scientiﬁc).
2.3. In vitro permeability assay
Solute permeability was tested using 6.5 mm transwell inserts
with 0.4 mm pore size (07–200-154, Fisher Scientiﬁc) as previouslydescribed [42]. Transwell inserts were coated with ﬁbronectin.
Endothelial cells were trypsinized and reconstituted in medium at
the concentration of 40,000 cells/ml. 250 μl cells (10,000 cells)
were seeded in ﬁbronectin coated transwell inserts and 1370 μl
mediumwas added to the bottom chamber. Cells were cultured for
36 h without changing medium. At the time of study, 25 μl albu-
min–ﬂuorescein isothiocyanate (FITC) conjugate (10 mg/ml)
(A9771–100MG, Sigma-Aldrich) with or without sulﬁde donors
was added to inserts. At certain time points, 50 μl medium was
collected from bottom chambers with 50 μl fresh medium added
back immediately. Sampled medium was diluted and ﬂuorescence
was measured at 495 nm/519 nm. For MAECs, phenol red free
DMEM (17–205-CV, Corning) was used for transwell permeability
assays. For transendothelial electrical resistance (TEER), transwell
inserts with endothelial monolayers were transferred to a cell
culture plate embedded with chopstick electrodes [11]. Cells were
allowed to rest for 20 min before the resistance was measured
using EVOM (World Precision Instruments).
2.4. In vivo permeability assay
In vivo permeability was examined by the modiﬁed Miles assay
as previously reported [8]. Evans blue (EB) (100 μl, 1% w/v in
normal saline) was delivered by tail vein immediately followed by
saline, vascular endothelial growth factor 165 (VEGF 165) (293-VE-
010) and sulﬁde donor injections in the ear pinna. After 30 min,
mice were euthanized and perfused with 5 ml PBS. Ears and in-
ternal organs were harvested. Samples were kept in micro-
centrifuge tubes and dried at 95 °C overnight on a heat block. EB
were extracted from dried tissue in 500 μl formamide at 55 °C for
2 days. EB concentration was determined by absorbance at
630 nm.
2.5. Immunocytochemistry and immunoblotting
For immunocytochemistry (ICC), cells were cultured on a glass
coverslip and ﬁxed with 4% formaldehyde and permeabilized
using 0.1% Triton X-100. Coverslips were blocked with 10% serum
and incubated with primary antibodies for 16 h. After thorough
rinsing in Tris buffered saline with 0.1% Tween-20, coverslips were
incubated with secondary antibodies for one hour. Images were
taken using Nikon NIS Elements. For western blotting (WB), cells
were lysed in 2X Laemmli sample buffer and boiled for 5 min.
Protein sample was then loaded on 10% SDS denaturing gels and
transferred to a PVDF membrane. Nonspeciﬁc proteins are blocked
with 5% non-fat milk. Proteins of interest are blotted for and ap-
propriate secondary antibodies are used for detection. Antibodies
and reagents used can be found in Supplementary Table 1.
2.6. Cellular hydrogen sulﬁde measurement in situ
Free sulﬁde was measured in cells using a speciﬁc ﬂuorescent
probe, sulﬁde ﬂuor-7 acetoxymethylester (SF7-AM) (748,110-1MG,
Sigma-Aldrich) [28]. Endothelial cells were incubated with 2.5 μM
SF7-AM in phenol red free for 30 min and rinsed with medium.
Cells were then treated with sulﬁde donors. Fluorescence was
measured at 495 nm/519 nm. The ﬂuorescent intensity at a certain
time point (F0) was divided by ﬂuorescent intensity at zero-time
point (Fi), denoted as F0/Fi. Result was presented as the fold
change of F0/Fi over control group.
2.7. Measurement of hydrogen sulﬁde metabolites
Sulﬁde metabolites were measured using HPLC as previously
reported (36,37). Brieﬂy, cells were lysed in the reaction buffer
(0.1 mM DTPA in 100 mM Tris, pH 9.5) with 0.1% Triton-X-100. For
S. Yuan et al. / Redox Biology 9 (2016) 157–166 159free sulﬁde, 70 μl sample, 30 μl reaction buffer and 50 μl mono-
bromobimane (MBB) solution (10 mM in acetylnitrile) were mixed
in a PCR tube and incubated for 30 min. The reaction was stopped
by adding 50 μl stopping solution (200 mM sulfosalicylic acid in
H2O) followed by 10-minute incubation on ice. For acid labile and
sulfane sulfur, 50 μl sample was injected into vacutainers. 450 μl
releasing buffer (0.1 mM diethylenetriaminepentaacetic acid
[DTPA], 100 mM phosphate buffer pH at 2.6) with or without
1 mM tris(2-carboxyethyl)phosphine (TCEP) were injected to the
vacutainers respectively. Tubes were incubated on a rocker for
30 min before the liquid phase was removed using a syringe with a
spinal needle. 500 μl reaction buffer was added to absorb the gas
phase left in the vacutainer. Eventually, the reaction buffer in the
vacutainer was allowed to react with MBB as the free sulﬁde
samples. All steps were performed in a hypoxic chamber (1%
oxygen) at room temperature. The ﬂuorescent product sulﬁde-
dibimane (SDB) is analyzed by reverse phase high performance
liquid chromatography using an eclipse XDB-C18 (4.6250 mm)
column with gradient elution by 0.1% (v/v) triﬂuoroacetic acid in
acetonitrile.
2.8. Cytotoxicity and apoptosis assay
Lactate dehydrogenase (LDH) release was measured in cell
culture medium using Pierce LDH Cytotoxicity Assay Kit (88,953,
Thermo scientiﬁc) according to the manufacture instruction. Cells
lysed with detergent (provided in the kit) was considered as 100%
release, while vehicle treatment was sat as 0%. Data were pre-
sented as a percentage of LDH release. Apoptosis was evaluated by
cleaved caspase-3 using western blotting.
2.9. Chemicals and reagents
Sulﬁde donors used in this study include sodium sulﬁde (Na2S)
(65,122-06, VWR SCIENTIFIC), GYY4137 (13,345, CaymanA
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Fig. 1. Exogenous hydrogen sulﬁde increased solute permeability. HUVECs were treat
polysulﬁde donors (D) in transwell inserts at indicated concentrations. FITC-albumin was
4 h. * indicates signiﬁcant difference from vehicle treatment group at the same time poChemical) and diallyl trisulﬁde (DATS) (10,012,577, Cayman Che-
mical), sodium disulﬁde (Na2S2), sodium trisulﬁde (Na2S3) and
sodium tetrasulﬁde (Na2S4) (SB02-10, SB03-10, SB04-10, Dojindo
Molecular Technologies). All donors were freshly prepared in de-
gassed distilled water and diluted with cell culture medium im-
mediately before treatments.
2.10. Statistics
Data were reported as mean7standard error of the mean
(SEM). In vitro experiments were repeated on different days. At
least 3 independent experiments were used for statistic analysis.
For transwell permeability assay, each independent experiment
was performed in replicates for each treatment. Statistical analysis
was performed with Graph Pad Prism using Student t-test, one-
way ANOVA and two-way ANOVA with Tukey post-hoc test.
P-values of o0.5 were considered as statistically signiﬁcant.3. Results
3.1. Effects of exogenous H2S on endothelial permeability in vitro
To examine the effect of exogenous H2S on endothelial solute
permeability, we ﬁrst measured albumin ﬂux across human um-
bilical vein endothelial cell (HUVEC) monolayer over 4 h after
treatments of two commonly used free sulﬁde donors, Na2S and
GYY4137. Both Na2S (5 μM–100 μM) and GYY4137 (20 μM–50 μM)
had little effect on permeability at low concentrations over a
4-hour time course (Fig. 1A-B). However, Na2S at 500 μM and
1 mM concentrations, increased permeability to 6.2970.88
(p¼0.0205) and 9.9670.24 (po0.0001) fold respectively al-
though these concentrations are not pathophysiologically relevant
(Fig. 1A). Similarly, 100 μM and 500 μM GYY4137 increased albu-
min ﬂux to 3.9070.31 (p¼0.0461) and 4.0470.23 fold0.5h 1h 2h 4h
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donor, diallyl trisulﬁde (DATS). In comparison, 20 μM DATS was
able to signiﬁcantly increase permeability 2.1070.3 fold quickly
within 30 min (p¼0.0281). Moreover, 50 μM or 100 μM DATS did
not further increase permeability at the 30-minute time point
(2.070.3 fold, p¼0.0395 and 2.470.3 fold, p¼0.0125). Increased
permeability induced by DATS (Z20 μM) was sustained up to 4 h
(po0.05), although no further increase over the control group was
observed after 30 min. To rule out potential effects of two allyl
groups of DATS, we also performed transwell permeability assays
with inorganic polysulﬁde compounds, Na2S2, Na2S3 and Na2S4.
Importantly, the more sulfur atom in the donor molecule, the
more potent it increased permeability (Fig. 1D). At the 30-minute
time point, 50 μM Na2S3 increased permeability 2.3670.19 fold
(p¼0.0199), producing similar responses as DATS at the same
concentration (1.9570.20, p¼0.0395). Therefore, for the rest of
this study we used DATS to investigate polysulﬁde induced
permeability.
3.2. Measurement of H2S metabolites
Na2S and GYY4137 are both free sulﬁde donors. Na2S releases a
bolus amount of H2S immediately upon hydration (peaks in sec-
onds with a half-life 5 min), whereas GYY4137 releases H2S
gradually and lasts longer (plateaus in minutes and lasts for hours)
[26,32]. Although DATS may generate H2S with cellular thiol me-
tabolism, it also serves as a persulﬁde donor. Thus it was im-
portant to distinguish whether changes in intracellular free sulﬁde
or polysulﬁde were associated with increased endothelial perme-
ability. To examine this, we ﬁrst measured intracellular free sulﬁde
using a speciﬁc ﬂuorescent probe, SF7-AM (Fig. 2A). After 30-
minute incubation of HUVECs with Na2S at 100 μM and 1 mM, the
ﬂuorescence increased 1.270.02 and 1.670.03 fold (po0.0001)
compared to the vehicle treatment group. GYY4137 (50 μM and
500 μM) also increased ﬂuorescence but to a lesser extentFi
/F
0
(F
ol
d
C
ha
ng
e)
0.5h 1h 2h 4h
0.0
0.5
1.0
1.5
2.0 Vehicle
Na2S 100μM
Na2S 1mM
GYY4137 50μM
GYY4137 500μM
DATS 5μM
DATS 50μM
*
*
* * *
*
** *
*
** *
*
**
nm
ol
/m
g
Ve
hic
le
Na
2S
 10
0μ
M
Na
2S
 1m
M
GY
Y4
13
7 5
0μ
M
GY
Y4
13
7 5
00
μM
DA
TS
5μ
M
DA
TS
50
μM
0.0
0.2
0.4
0.6
0.8 Free Sulfide
Acid Labile Sulfur
Bound Sulfur
*
*
*
*
#
Fig. 2. Na2S and GYY4137 increased free sulﬁde while DATS increased bound sul-
fane sulfur. A: HUVECs were pre-incubated with SF7-AM for 30 min and rinsed
with medium. Sulﬁde donors were given to cells at indicated concentrations.
Fluorescent intensity was measured at different time points. * indicates signiﬁcant
difference between vehicle treatment at the same time point (n¼6, po0.05). B:
HUVECs were treated with sulﬁde donors at indicated concentrations. Sulﬁde pools
were measured by the MBB method. * indicates signiﬁcant difference from vehicle
treatment. # indicates signiﬁcant difference from GYY4137 (50 μM and 500 μM)
and DATS 5 μM. N¼3–6, po0.05.(1.170.01 fold, po0.0001). However, none of the treatments
further increased ﬂuorescence intensity after 30 min. Importantly,
DATS did not increase SF7-AM signal over a 4-hour time course
(Fig. 2A).
Next we performed analytical measurement of deﬁned H2S
biochemical pools after 4-hour donor treatments in HUVECs using
the MBB method (Fig. 2B). Neither free H2S nor acid labile sulfur
were signiﬁcantly increased by various donors at 4 h. Conversely,
50 μM DATS, which was most effective at inducing permeability,
increased bound sulfane sulfur from 0.11270.041 to 0.54970.065
nmol per mg total protein (po0.0001). 5 μM DATS and GYY4137
(50 μM and 500 μM) also increased bound sulfane sulfur but to a
substantially lower amount than 50 μM DATS (po0.05). These
data suggest there is a threshold of polysulﬁde levels that stimu-
lates increased endothelial solute permeability.
3.3. Effects of free sulﬁde and polysulﬁde on cell-to-cell junction and
actin cytoskeleton
Increased solute permeability is regulated primarily through
cell-to-cell junctions composed of tight and adherens junctions.
This pathway is regulated by structural proteins such as claudin-5
at tight junctions and VE-cadherin and β-catenin at adherens
junctions. Disruption of these proteins compromises endothelial
barrier function. We performed immunostaining for claudin-5, VE-
cadherin and β-catenin in HUVECs treated with 500 μM Na2S or
20 μM DATS. Continuous strands of claudin-5 and VE-cadherin
indicate integrity of tight junctions and adherens junctions, re-
spectively. Conversely, discontinuous and interdigitated junctional
protein alignment indicates disruption of cell-to-cell junctions. By
comparison, DATS treatment resulted in substantial loss and dis-
ruption of claudin 5 and VE cadherin at endothelial junctions
(Fig. 3A). Conversely, Na2S treatment did not alter endothelial
junctional protein localization similar to DATS. Enhanced actin
stress ﬁber formation contributes to increased paracellular per-
meability and facilitates junction disruption [22]. Interestingly,
DATS but not Na2S increased actin stress ﬁber formation as seen by
phallodin staining. This is further evidenced by differential effects
of sulﬁde donors on myosin light chain phosphorylation (p-MLC).
DATS (50 μM) increased p-MLC 5.472.7 fold (p¼0.0024) (Fig. 3B);
whereas, none of the other donors similarly affected p-MLC. Thus,
polysulﬁde is most potent at disrupting endothelial cell junctions
and inducing stress ﬁber formation.
3.4. Effects of free sulﬁde and polysulﬁde on cell survival
To determine whether sulﬁde donor mediated changes in
permeability were due to cytotoxicity, we performed the LDH re-
lease assay to examine cell viability. HUVECs were treated with
Na2S, GYY4137 or DATS for 4 h at various doses that did or did not
alter permeability. None of the sulﬁde donor treatments showed
signiﬁcant toxicity within the four-hour study period (p40.05)
(Fig. 4A). Similarly, the level of cleaved caspase 3 was also not
increased, indicating that treatments did not induce apoptosis
(p40.05) (Fig. 4B). Therefore, treatment cytotoxicity is not con-
tributing to endothelial solute permeability changes.
3.5. Effects of CSE expression on endothelial barrier function
Next, we examined whether endogenous H2S and polysulﬁde
contributes to regulation of endothelial permeability. To in-
vestigate the role of CSE, aortic endothelial cells from both wild-
type and CSE knockout mice were isolated and used in culture.
MAECs isolated from CSE knockout mice had only 60.973.5% ac-
cumulative albumin ﬂux over 4-hour time course compared to
wild-type MAECs (po0.0001), revealing that CSE knockout
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transendothelial electrical resistance (TEER) was found to be
1.5670.2 fold greater in CSE knockout MAECs compared to wild-
type MAECs (p¼0.0114), indicating tighter barrier properties
(Fig. 5B).
To independently conﬁrm this observation, we performed CSE
siRNA knockdown experiments in HUVEC and examined junc-
tional protein and actin cytoskeleton staining. HUVECs with re-
duced CSE expression revealed greater junction protein alignment
of claudin-5, β-catenin, and VE cadherin along with decreased
stress ﬁber formation across the cell (Fig. 5C). Western blotting
revealed that claudin-5 expression level was signiﬁcantly elevated
1.670.4 fold in CSE knockdown HUVECs (p¼0.0098) (Fig. 5D).
These data demonstrate that lack of CSE expression improves
junction barrier function by enhancing tight junctions.
3.6. Polysulﬁdes regulate permeability in CSE deﬁcient MAECs
Since CSE maintains a basal level of endothelial permeability,
we next wanted to know whether it is free sulﬁde or polysulﬁde
that mediates this effect. To answer this question, we ﬁrst mea-
sured free sulﬁde levels in MAECs using SF7-AM. Interestingly,
there was not a signiﬁcant difference in SF7-AM intensity between
wild type and CSE knockout MAECs (p¼0.7401) (Fig. 6A). Simi-
larly, free H2S levels measured by MBB method also did not differbetween the two cell types (p¼0.2032) (Fig. 6B). However, the
level of bound sulfane sulfur was 0.15670.06 nmol/mg total
protein in wild type MAECs and signiﬁcantly reduced to
0.08670.03 nmol/mg total protein in CSE knockout MAECs
(Fig. 6B). CSE deﬁciency in MAECs resulted in 44.9718.8% de-
crease in the bound sulfane sulfur pool, which contains poly-
sulﬁdes (p¼0.0289). To determine whether polysulﬁde is sufﬁ-
cient to restore endothelial solute permeability, we treated CSE
knockout MAECs with DATS. We found 20 μM DATS was sufﬁcient
to recover permeability in CSE knockout MAECs to the same level
as wild-type MAECs at 2-hour and 4-hour time points (po0.05)
(Fig. 6C). Thus, CSE regulates endothelial permeability through
polysulﬁde formation.
3.7. Effect of CSE expression on endothelial permeability in vivo
Since CSE critically regulated endothelial solute permeability in
vitro, we next examined whether the same effect would be found
in vivo. To study permeability in vivo, we performed a Miles assay
on the ear pinna with normal saline and VEGF 165 (400 ng per
injection, 40 ng/ml) injections. VEGF mediated solute permeability
was signiﬁcantly blunted in CSE knockout mice (215736 ng EB/
mg dry tissue, p¼0.0493) compared to wild type mice
(342797 ng EB/mg dry tissue) (Fig. 7A). Potential differences in
basal solute permeability using the EB assay was also tested in
various organs which were not signiﬁcantly different between
wild type and CSE knockout mice (p40.05) (Fig. 7B). Thus, in vivo
permeability appears to be selectively regulated by CSE.4. Discussion
The regulation of endothelial permeability is important for
vascular health. While basal permeability maintains normal solute
exchange, vascular hyperpermeability precedes and accompanies a
vast array of pathological and physiological events such as in-
ﬂammation, tumorigenesis, ischemic injury, wound healing and
development. The opening of the endothelial paracellular pathway
is critical for leukocyte extravasation, which is blocked when
junctions are stabilized [35,39]. Moreover, increased vascular
permeability enhances angiogenesis via deposition of extracellular
matrix from blood plasma, while reduced permeability is asso-
ciated with impaired angiogenesis [5,10,13]. Therefore, endothelial
permeability is ﬁne-tuned in order to adapt to various conditions.
However, it was previously not known whether H2S regulates
endothelial solute permeability and how this may occur.
Studies have reported that H2S therapy has protective effects
against particulate matter or ischemia/reperfusion induced vas-
cular permeability [14,41]. However, these studies did not examine
roles or mechanisms of H2S metabolites on endothelial perme-
ability rather permeability changes were considered as a con-
sequence of pathophysiological events. Additionally, no studies to
date have investigated important questions regarding sulﬁde
metabolism and permeability including what sulfur species is
biologically active, what endogenous cellular sources are im-
portant, and what molecular mechanisms are involved. Our cur-
rent study provides clear insight into all of these aspects.
To begin with, polysulﬁdes (e.g. DATS), but not Na2S or
GYY4137, most potently and rapidly increase endothelial perme-
ability in vitro. Although DATS can potentially release free sulﬁde
[34], this process typically requires thiol dependent reduction in
the cell [4,27]. Importantly, our data reveals that DATS and other
polysulﬁdes act distinctly different than free sulﬁde or GYY4137
highlighting key physiological differences between these moieties.
Polysulﬁde species are reactive and can interact with thiols, in-
cluding small molecular thiols (e.g. glutathione [GSH]) and protein
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or greater reactivity than reactive oxygen species (ROS) and are
therefore named reactive sulfur species (RSS) [12].
By comparison, neither Na2S nor GYY4137 are effective per-
meability inducers compared to polysulﬁdes. Instead, they only
increased permeability at high concentrations. Exposure to high
level of H2S is known to be toxic by mitochondrial inhibition. But
in our studies, the permeability induced by these treatments was
not a result of cytotoxicity. This may be due to the short half-life of
free H2S (5 min) in an open environment such as cell culture and
the fact that high concentrations of free sulﬁde can lead to poly-
sulﬁde formation[16,32].
An important ﬁnding of our study is that CSE expressionregulates basal endothelial solute permeability. Our group and
others have shown sulﬁde can be stored in three biochemical re-
servoirs: free sulﬁde (i.e. H2S, HS , S2), acid labile sulfur (e.g. iron
sulfur clusters) and sulfane sulfur (e.g. persulﬁde, polysulﬁde) [37].
Under certain circumstances, one biological pool may be mobi-
lized. Importantly, one electron oxidation of free sulﬁde, in the
presence of free radicals, ion metals and peroxidases, gives rise to
sulfhydryl radical and subsequent RSS. It is worth noting that
under basal conditions, endothelial cells have more sulfane sulfur
content than free sulﬁde. Moreover, lack of CSE in endothelial cells
signiﬁcantly reduced sulfane sulfur level rather than free sulﬁde.
This is consistent with the hypothesis of CSE as an enzymatic
source of polysulﬁde [18].
S. Yuan et al. / Redox Biology 9 (2016) 157–166 165Both exogenous polysulﬁde and endogenous bound sulfane
sulfur derived from CSE regulate endothelial permeability. As
previously mentioned, polysulﬁde may induce post-translational
modiﬁcation on labile cysteine residues. Such modiﬁcations often
change the conformation and function of target molecules [43]. In
our study, it is possible that polysulﬁde induces junction protein
disruption and stress ﬁber formation via post-translational mod-
iﬁcation. Potential candidate molecules are suggested in the lit-
erature as targets of post-translational modiﬁcations. Phosphor-
ylation of β-catenin dissociates it from VE-cadherin and destabi-
lizes endothelial cell-cell junctions [7,9,17]. Additionally, S-ni-
trosation of β-catenin has been reported be important for VEGF
induced hyperpermeability [38]. Likewise, the endothelial actin
cytoskeleton also critically regulates endothelial permeability. It is
possible that actin thiol sulfhydration may also play a role in
permeability responses, as sulﬁde modiﬁcation of actin leads to
increase polymerization [31]. Upstream signaling pathways con-
trolling the arrangement of actin cytoskeleton could also affect
junction stability. Phosphorylation of MLC on Thr-18/Ser-19 in-
duces stress ﬁber formation causing paracellular pores [1,20,33]. It
is evident that 50 μM but not 5 μM DATS increased MLC phos-
phorylation. This dose-dependent effect is similar to H2O2 induced
MLC phosphorylation except that DATS derived polysulﬁde is more
effective [44]. Moreover, loss of CSE expression up-regulated
claudin-5 expression and enhanced tight junction arrangement
highlighting yet another way to modulate endothelial barrier
function. Together, these ﬁndings reveal a new area of reactive
sulfur species regulation of endothelial solute barrier that requires
much more investigation.
The physiological importance of sulﬁde regulating solute bar-
rier function is reﬂected by defective VEGF mediated permeability
in CSE knockout mice. This ﬁnding suggests that stimulation of
sulﬁde formation via CSE is likely critical for numerous vascular
physiological functions. Consistent with this idea, we recently re-
ported that CSE knockout mice have compromised angiogenesis
activity in the hind limb ischemia model [24,25]. It is well un-
derstood that VEGF induced angiogenesis requires disruption of
endothelial junctions that facilitates endothelial cell migration and
tip cell formation. Thus, these data provide a potential molecular
mechanism whereby loss of CSE results in defective VEGF en-
dothelial cell activation, leading to lesser junction alterations and
decreased angiogenesis. However, future studies are clearly nee-
ded to better understand how CSE and resulting endogenous
sulﬁde metabolites regulate endothelial cell activation responses.5. Conclusions
In summary, our report reveals novel and critically important
roles of exogenous sulﬁde treatments and endogenous CSE de-
pendent regulation of sulﬁde metabolite formation in regulating
endothelial permeability mainly via polysulﬁde mechanisms.
Polysulﬁdes may in turn lead to alterations of small molecular
targets including post-translational modiﬁcation of proteins to
regulate endothelial junctions and signaling molecules. Regulation
of sulﬁde metabolism represents a new and important pathway
with which to regulate vascular permeability responses.Acknowledgments
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